secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001213900-25-033402
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx plans new independent director in H2 2025; Whetstone withdraws nomination notice
--------------------------------------------------------------------------------

- Plans to add a new independent director in H2 2025 as part of ongoing board refreshment.
- Whetstone Capital Advisors withdrew its March 6 director nomination notice after constructive engagement.
- Current board has five members; three new directors added since 2020 including Klema (2024) and Wasson (2020).
- Chairperson Lynn Vos cites progress under CEO Steve Silvestro and commitment to recruiting qualified directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/0001213900-25-033402-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/ea0238866-8k_optimize.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-033402

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer